rs770067057

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_005120.3(MED12):​c.5253G>A​(p.Pro1751Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000005 in 1,200,479 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1751P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.0000037 ( 0 hom. 0 hem. )

Consequence

MED12
NM_005120.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.958

Publications

0 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-71136508-G-A is Benign according to our data. Variant chrX-71136508-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 458819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.958 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.5253G>A p.Pro1751Pro synonymous_variant Exon 37 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.5253G>A p.Pro1751Pro synonymous_variant Exon 37 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.0000180
AC:
2
AN:
110899
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000657
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000188
AC:
3
AN:
159347
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000393
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000146
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000367
AC:
4
AN:
1089580
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
356806
show subpopulations
African (AFR)
AF:
0.0000382
AC:
1
AN:
26199
American (AMR)
AF:
0.0000294
AC:
1
AN:
33988
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19260
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29878
South Asian (SAS)
AF:
0.0000188
AC:
1
AN:
53170
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39986
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3465
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
837933
Other (OTH)
AF:
0.00
AC:
0
AN:
45701
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000180
AC:
2
AN:
110899
Hom.:
0
Cov.:
21
AF XY:
0.0000301
AC XY:
1
AN XY:
33171
show subpopulations
African (AFR)
AF:
0.0000657
AC:
2
AN:
30449
American (AMR)
AF:
0.00
AC:
0
AN:
10467
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2638
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3525
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2613
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5975
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52833
Other (OTH)
AF:
0.00
AC:
0
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 12, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FG syndrome Benign:1
Sep 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
4.8
DANN
Benign
0.80
PhyloP100
-0.96
PromoterAI
0.0086
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770067057; hg19: chrX-70356358; API